
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Oral doublets and improving MRD with novel BCL2
Tam covers BTKi+BCL2 oral doublets and rationale for upgrading venetoclax to more potent agents like somerotoclax.
Play episode from 02:49
Transcript


